The molecular design method of thermally activated delayed fluorescent emitters for blue-shifted emission was developed by modifying a phenyl linker using a methoxy substituent.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: